178 related articles for article (PubMed ID: 28083838)
21. High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer.
Fang P; Jiang W; Davuluri R; Xu C; Krishnan S; Mohan R; Koong AC; Hsu CC; Lin SH
Radiother Oncol; 2018 Sep; 128(3):584-590. PubMed ID: 29530432
[TBL] [Abstract][Full Text] [Related]
22. Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy.
Zeng YC; Chi F; Xing R; Xue M; Wu LN; Tang MY; Wu R
Jpn J Clin Oncol; 2016 Feb; 46(2):126-31. PubMed ID: 26611205
[TBL] [Abstract][Full Text] [Related]
23. A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma.
Liang S; Li C; Gao Z; Li J; Zhao H; Yu J; Meng X
Int Immunopharmacol; 2021 Jan; 90():107178. PubMed ID: 33218939
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy.
Wang D; Wu M; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Chin Med J (Engl); 2013; 126(8):1464-8. PubMed ID: 23595378
[TBL] [Abstract][Full Text] [Related]
25. Can pretreatment blood biomarkers predict pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer?
Morais M; Fonseca T; Machado-Neves R; Honavar M; Coelho AR; Lopes J; Barbosa E; Guerreiro E; Carneiro S
Future Oncol; 2021 Dec; 17(35):4947-4957. PubMed ID: 34734533
[No Abstract] [Full Text] [Related]
26. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
Braun LH; Baumann D; Zwirner K; Eipper E; Hauth F; Peter A; Zips D; Gani C
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108935
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.
Qi WX; Wang X; Li C; Li S; Li H; Xu F; Chen J; Zhao S; Li H
Thorac Cancer; 2023 Jun; 14(17):1556-1566. PubMed ID: 37089116
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
30. Can Haematology Blood Tests at Time of Diagnosis Predict Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer?
Ramsay G; Ritchie DT; MacKay C; Parnaby C; Murray G; Samuel L
Dig Surg; 2019; 36(6):495-501. PubMed ID: 30269129
[TBL] [Abstract][Full Text] [Related]
31. After neoadjuvant chemotherapy platelet/lymphocyte ratios negatively correlate with prognosis in gastric cancer patients.
Gong W; Zhao L; Dong Z; Dou Y; Liu Y; Ma C; Qu X
J Clin Lab Anal; 2018 Jun; 32(5):e22364. PubMed ID: 29251364
[TBL] [Abstract][Full Text] [Related]
32. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
[TBL] [Abstract][Full Text] [Related]
33. Good prediction of treatment responses to neoadjuvant chemoradiotherapy for esophageal cancer based on preoperative inflammatory status and tumor glucose metabolism.
Li C; Lin JW; Yeh HL; Chuang CY; Chen CC
Sci Rep; 2021 Jun; 11(1):11626. PubMed ID: 34078965
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients.
Messager M; Neofytou K; Chaudry MA; Allum WH
Eur J Surg Oncol; 2015 Oct; 41(10):1316-23. PubMed ID: 26166786
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.
Jia W; Yuan L; Ni H; Xu B; Zhao P
Technol Cancer Res Treat; 2021; 20():15330338211034291. PubMed ID: 34308689
[TBL] [Abstract][Full Text] [Related]
37. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
[TBL] [Abstract][Full Text] [Related]
38. Elevated Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio after First Cycle of Chemotherapy and Better Survival in Esophageal Cancer Patients Receiving Concurrent Chemoradiotherapy.
Tseng RH; Lai KM; Tsai CY; Yan SL
Curr Oncol; 2022 Nov; 29(11):8825-8834. PubMed ID: 36421347
[No Abstract] [Full Text] [Related]
39. Low lymphocyte monocyte ratio after neoadjuvant therapy predicts poor survival after pancreatectomy in patients with borderline resectable pancreatic cancer.
Kawai M; Hirono S; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Tanioka K; Yamaue H
Surgery; 2019 Jun; 165(6):1151-1160. PubMed ID: 30765142
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study.
Ertekin SS; Mangas C; Riquelme-Mc Loughlin C; Carrera C; Malvehy J; Puig S; Podlipnik S
Acta Derm Venereol; 2024 Apr; 104():adv27571. PubMed ID: 38655656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
